Owner Monogram Biosciences, Inc a Delaware corporation

Convention US 9 June 2005 78/647,381

Service Baldwins

Filing Date 9 December 2005

Class 42 Medical testing and diagnostic laboratory services and development of therapy guidance tools, namely, drug susceptibility resistance tests for guiding the treatments of diseases; drug discovery and testing services, namely medical research and biological sample testing through medical data collected through performance of viral assays and such data is provided to others for pharmaceutical drug development, and for drug sensitivity and resistance testing; pharmaceutical drug development services, namely, providing drug testing, screening, validation and analysis services for others

Class 44 Medical testing, namely, diagnostic and prognostic biological sample testing to determine drug sensitivity and resistance testing for others